Psilocybin
What Does Oregon’s Legalization Mean for Me?: Mindshifting Moments #18
In this edition of Mindshifting Moments, Margaret Williamson is joined by Todd Shapiro and Sarah Hashkes of Red Light Holland. The conversation answers…
In this edition of Mindshifting Moments, Margaret Williamson is joined by Todd Shapiro and Sarah Hashkes of Red Light Holland.
The conversation answers the following questions:
- What supporting tools can the psychedelic industry provide customers to make the most out of psychedelics?
- Is the future of psychedelics natural substance legalization? – what can we learn from Oregon legalization and the long-term legalization in the Netherlands of natural psilocybin?
- Microdosing, what does the latest science show?
- How to make the most out of psychedelics to “change your mind”?
More About Red Light Holland
Red Light Holland’s business revolves around the production, growth, and sale (through existing Smart Shops operators) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, and in compliance with all applicable laws. Red Light Holland is strategically based in the Netherlands, an area with a long-standing, established legal magic truffles market.
Transcription
The transcription will be available after the event.
-
Psychedelics1 week ago
Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder
-
Law & Regulation1 week ago
Going concern warnings cloud Xtacy Therapeutics’ shrunk losses
-
Psilocybin1 week ago
Are Shrooms Legal in Oregon: Full Guide
-
Law & Regulation1 week ago
Numinus reports declining revenue as the company restructures
-
Psychedelics1 week ago
Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)
-
Psychedelics1 week ago
Atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
-
Psychedelics1 week ago
Psyence Group’s NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
-
Law & Regulation7 days ago
Clearmind signs agreement with Hebrew University for psychedelic compound rights